JP2022510780A5 - - Google Patents

Info

Publication number
JP2022510780A5
JP2022510780A5 JP2021524290A JP2021524290A JP2022510780A5 JP 2022510780 A5 JP2022510780 A5 JP 2022510780A5 JP 2021524290 A JP2021524290 A JP 2021524290A JP 2021524290 A JP2021524290 A JP 2021524290A JP 2022510780 A5 JP2022510780 A5 JP 2022510780A5
Authority
JP
Japan
Prior art keywords
optionally
subject
cacae
prebiotic
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524290A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022510780A (ja
JP7737098B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/059865 external-priority patent/WO2020097077A1/en
Publication of JP2022510780A publication Critical patent/JP2022510780A/ja
Publication of JP2022510780A5 publication Critical patent/JP2022510780A5/ja
Application granted granted Critical
Publication of JP7737098B2 publication Critical patent/JP7737098B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021524290A 2018-11-05 2019-11-05 感染性疾患、自己免疫疾患、およびアレルギー性疾患を治療するための方法および組成物 Active JP7737098B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862755945P 2018-11-05 2018-11-05
US62/755,945 2018-11-05
PCT/US2019/059865 WO2020097077A1 (en) 2018-11-05 2019-11-05 Methods and compositions for treating infectious, autoimmune, and allergic disease

Publications (3)

Publication Number Publication Date
JP2022510780A JP2022510780A (ja) 2022-01-28
JP2022510780A5 true JP2022510780A5 (cg-RX-API-DMAC7.html) 2022-11-10
JP7737098B2 JP7737098B2 (ja) 2025-09-10

Family

ID=70611079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524290A Active JP7737098B2 (ja) 2018-11-05 2019-11-05 感染性疾患、自己免疫疾患、およびアレルギー性疾患を治療するための方法および組成物

Country Status (9)

Country Link
US (1) US12589122B2 (cg-RX-API-DMAC7.html)
EP (1) EP3876755A4 (cg-RX-API-DMAC7.html)
JP (1) JP7737098B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210098464A (cg-RX-API-DMAC7.html)
CN (1) CN113271796A (cg-RX-API-DMAC7.html)
AU (1) AU2019374773B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021008767A2 (cg-RX-API-DMAC7.html)
CA (1) CA3118679A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020097077A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113271796A (zh) 2018-11-05 2021-08-17 芝加哥大学 用于治疗感染性、自身免疫和过敏性疾病的方法和组合物
WO2022020852A1 (en) * 2020-07-22 2022-01-27 The University Of Chicago Methods and compositions for treating autoimmune and allergic disorders
US11334352B1 (en) 2020-12-29 2022-05-17 Kpn Innovations, Llc. Systems and methods for generating an immune protocol for identifying and reversing immune disease
JP7124148B1 (ja) * 2021-03-08 2022-08-23 Varinos株式会社 微生物叢のメタゲノム解析
EP4426354A4 (en) * 2021-11-03 2025-10-08 Univ Chicago PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR DELIVERY OF SHORT-CHAIN FATTY ACIDS, PROMOTION OF GUT HEALTH, AND TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY
WO2025183115A1 (ja) * 2024-02-28 2025-09-04 三菱ケミカル株式会社 乳酸産生菌及び酪酸産生菌を含む整腸用組成物
CN120843703A (zh) * 2025-07-24 2025-10-28 上海市生物医药技术研究院 一种利用癌组织的特定微生物预测乳腺癌原位复发的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
CA2683383C (en) 2007-02-21 2016-01-05 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
ES2993669T3 (en) 2011-12-01 2025-01-03 Univ Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
US20140161878A1 (en) * 2012-12-12 2014-06-12 Sweet Wellness AB Multi-nutrient supplement and uses thereof
US9956282B2 (en) * 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
JP6754694B2 (ja) 2014-03-06 2020-09-16 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル プロバイオティクス製剤および使用のための方法
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2016149687A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
CN115252650A (zh) 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
EP3639834B1 (en) 2016-02-04 2023-07-12 Universiteit Gent Use of microbial communities for human and animal health
US20200016256A1 (en) 2016-09-22 2020-01-16 The University Of Chicago Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization
WO2018075886A1 (en) 2016-10-21 2018-04-26 The University Of Chicago Compositions and methods for inducing immune system maintenance to prevent and/or treat infections
CA3045026A1 (en) 2016-12-06 2018-06-14 Whole Biome Inc. Methods and compositions relating to isolated and purified microbes
WO2018107365A1 (zh) * 2016-12-13 2018-06-21 深圳华大基因研究院 粪厌氧棒杆菌(Anaerostipes caccae)及其应用
WO2018129249A1 (en) 2017-01-05 2018-07-12 The University Of Chicago Inhibition of enteric infection through the modulation of microbiota
EP3606325B1 (en) * 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
CN113271796A (zh) 2018-11-05 2021-08-17 芝加哥大学 用于治疗感染性、自身免疫和过敏性疾病的方法和组合物
ES2763874B2 (es) 2018-11-30 2020-10-13 Consejo Superior Investigacion Phascolarctobacterium faecium para su uso en la prevencion y tratamiento de la obesidad y sus comorbilidades

Similar Documents

Publication Publication Date Title
JP2022510780A5 (cg-RX-API-DMAC7.html)
CN102905558B (zh) 免疫系统印记的营养组合物
Thomas et al. Probiotics and prebiotics in pediatrics
Pregliasco et al. A new chance of preventing winter diseases by the administration of synbiotic formulations
JP2019123752A (ja) プレバイオティック製剤および使用方法
CN107405354A (zh) 治疗急性呼吸道感染的组合物和方法
US20170173093A1 (en) Methods of using smectite compositions for treating clostridium difficile associated diseases and symptoms
KR102708415B1 (ko) 프로바이오틱 및 프리바이오틱의 조합을 포함하는 발육부진을 치료하기 위한 약학적 조성물
US20240197797A1 (en) Pharmaceutical composition comprising a probiotic and prebiotic to prevent acquisition of or treat drug resistant infections
EP4041285B1 (en) Gastrointestinal health composition
Wei et al. The impact of combined therapy with Lactobacillus acidophilus and montmorillonite powder on the inflammatory response in pediatric rotavirus enteritis
CN104039175A (zh) 使用非消化性低聚糖的变态反应疗法
CN102917716B (zh) 免疫印记的营养组合物
Tafrishi et al. Development and clinical assessment of a novel probiotic candy in the prevention of respiratory infections in asthmatic children
Riedel Clinical significance of Bifidobacteria
CN116948897A (zh) 植物乳杆菌kfy02在制备调节早期抗生素引起的肠道菌群紊乱的药品或食品中的应用
CN118973562A (zh) 用于预防或减轻感染性疾病的一种或多种急性后症状的包含烟酰胺、烟酰胺前体、烟酰胺代谢物或其组合的组合物
CN117089483A (zh) 发酵乳杆菌cqpc04在制备调节早期抗生素引起的肠道菌群紊乱的药品或食品中的应用
CN112261945A (zh) 用于治疗银屑病的益生菌
CN106974940A (zh) 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
CN116635025A (zh) 用于缩短covid-19和其他病毒感染患者的症状消退时间的烟酰胺、烟酰胺前体和烟酰胺代谢物及其组合物
HK40078260B (en) Gastrointestinal health composition
HK40078260A (en) Gastrointestinal health composition
JP2021014422A (ja) 便性改善剤
HK1239568B (zh) 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用